Joana Revés

5PUBLICATIONS
8CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 23, 2026
Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab.

|Sep 02, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocol.

Joana Revés, Anthony Buisson, Johan Burisch

|Sep 04, 2024
Cholangioscopic findings in complicated liver hydatid disease.

Joana Revés, Bénédicte Delire, Alice Dongier

|Jan 17, 2024
Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel Diseases.

Joana Revés, Joana Torres

|May 23, 2023
Early intervention with biologic therapy in Crohn´s disease: how early is early?

Joana Revés, André Mascarenhas, Maria José Temido

Pageof 1

Frequent Collaborators

3 joint publications

Joana Torres

1 joint publications

Anthony Buisson

1 joint publications

Johan Burisch

1 joint publications

Sophie Vieujean